Preclinical data highlight that PKM2 modulation inhibits several important mechanisms underlying atopic dermatitis ...

Altimmune’s pemvidutide shows promising Phase IIb MASH results; see key benefits, risks, and a bullish outlook. Read here for ...

Shunyalabs.ai has launched ZeroMed, a next-generation automatic speech recognition (ASR) system designed specifically for healthcare environments. The company calls it “a breakthrough domain-optimized ...

New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in human keratinocytes, demonstrating potent cell penetration and ...

Opinion: A Middle East rapid-response force would not only deter aggression — it would symbolize a new era of partnership and ...

Shares of Engene Holdings Inc. (NASDAQ:ENGN) were trading at $10.34, up $4.33, or 72%, on word of additional preliminary data from the pivotal cohort of its ongoing phase II Legend trial testing ...

Network participation on Solana has dropped sharply, with the seven-day average of daily active addresses falling to about ...

Paysafe Limited uses a debt-heavy capital structure, creating the potential for significant share price swings. Learn more ...

Five AI-focused stocks led by Microsoft, Nvidia, and Amazon earn strong analyst ratings with multi-year growth catalysts ...

Epstein sees a clear direction of travel in private markets. “The trend line is toward standardized data and repeatable ...

The research aim is to develop an intelligent agent for cybersecurity systems capable of detecting abnormal user behavior ...

The plain, though somewhat striking, reality is that Advanced Micro Devices’ ($AMD) share price has more than doubled this ...